STING1 and neoplasm: Colorectal cancer (CT26) BALB/c mouse models were treated with intravenous HMME@Bif and SR717, a STING-agonist, and then ultrasound irradiation was used to activate the sono-sensitive HMME, thus generating reactive oxygen species thought to be responsible for the destruction of tumor cells.